Overview

BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Objective: The purpose of this study is to evaluate the effect of food intake in bioavailability (BA) of the combination Glimepiride/ extended release Metformin GLI/METXR (4/850mg) in healthy Mexican volunteers. Methods: A prospective, longitudinal, open label, non randomized study, was performed. A single oral dose of GLI/METXR (4/850 mg) was administered to 24 health Mexican volunteers 30 min after a high fat meal.
Phase:
Phase 1
Details
Lead Sponsor:
Laboratorios Silanes S.A. de C.V.
Collaborator:
Instituto Mexicano del Seguro Social
Treatments:
Glimepiride
Metformin